Works matching IS 20457022 AND DT 2024 AND VI 14 AND IP 9
Results: 8
High‐risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system database.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12392
- By:
- Publication type:
- Article
Advent of oral medications for the treatment of hereditary angioedema.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12391
- By:
- Publication type:
- Article
Atopic Dermatitis Activity Score 7 (ADAS7): A tool for disease activity assessment.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12393
- By:
- Publication type:
- Article
Eczema in early childhood increases the risk of allergic multimorbidity.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12384
- By:
- Publication type:
- Article
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12390
- By:
- Publication type:
- Article
Risk factors investigation for different outcomes between unilateral and bilateral chronic rhinosinusitis with nasal polyps patients.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12395
- By:
- Publication type:
- Article
The impact of COVID‐19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12394
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Translational Allergy, 2024, v. 14, n. 9, p. 1, doi. 10.1002/clt2.12261
- Publication type:
- Article